FDA decision on Avandia

So this is a follow up to the post a couple months ago on the fate of Avandia.  In short, the manufacturer of the drug hid data about its safety.  It turns out the drug increases your risk for heart attack.  In light of the danger and the obfuscation by the drug company, the FDA put Avandia back under review. Last week the FDA finally released their decision, which was to change the status of Avandia to only be prescribed for diabetics who do not respond to safer drugs on the market.  Now, while I admit I would have liked the FDA to have removed the drug completely from the market, the fact that the drug does help some diabetics does make it worthwhile to keep around.  I do wish, however, the FDA would have taking a much harder stance on the drug company itself.  Sadly, the current state of the FDA, both its dependence on corporate money, and its lack of true regulatory power, would have made that option highly unlikely.